![Dentistry Journal | Free Full-Text | Management of Trigeminal Neuralgia with Botulinum Toxin Type A: Report of Two Cases Dentistry Journal | Free Full-Text | Management of Trigeminal Neuralgia with Botulinum Toxin Type A: Report of Two Cases](https://pub.mdpi-res.com/dentistry/dentistry-10-00207/article_deploy/html/images/dentistry-10-00207-ag.png?1667561691)
Dentistry Journal | Free Full-Text | Management of Trigeminal Neuralgia with Botulinum Toxin Type A: Report of Two Cases
![Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia - The Lancet Neurology Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia - The Lancet Neurology](https://www.thelancet.com/cms/attachment/aa4b4083-1771-4c62-b3f9-7ae5b05621cd/gr2_lrg.jpg)
Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia - The Lancet Neurology
![A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia - ScienceDirect A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0007091219304301-gr3.jpg)
A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia - ScienceDirect
![Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study - The Lancet Neurology Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study - The Lancet Neurology](https://www.thelancet.com/cms/attachment/988df240-3816-473d-af65-1646413af675/gr1_lrg.jpg)